activins has been researched along with Neoplasms in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.00) | 18.2507 |
| 2000's | 10 (25.00) | 29.6817 |
| 2010's | 23 (57.50) | 24.3611 |
| 2020's | 5 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hagg, A; Harrison, CA; O'Shea, E; Walton, KL | 1 |
| Chen, D; Chen, G; Chen, P; Chen, X; Gu, Y; Leng, D; Li, X; Liu, W; Song, C; Wang, X; Wu, H; Wu, Q; Xiao, J; Xie, S; Ye, Y; Zhang, W; Zhao, Q | 1 |
| Morianos, I; Papadopoulou, G; Semitekolou, M; Xanthou, G | 1 |
| Falch, D; Grusch, M; Hoda, MA; Pany, L; Ries, A; Schelch, K | 1 |
| Cao, Z; Glab, J; Hoogenraad, NJ; Jose, I; Osellame, LD; Puthalakath, H | 1 |
| Cangkrama, M; Werner, S; Wietecha, M | 1 |
| de Barsy, M; Gruson, D; Lause, P; Loumaye, A; Nachit, M; Thissen, JP; Trefois, P; van Maanen, A | 1 |
| Bloxham, RD; Chakravarty, P; Das, D; Gori, I; Hill, CS; Howell, M; Jiang, M; Miller, DSJ; Saunders, RE | 1 |
| Baek, JY; Hong, DS; Hong, S; Hong, YS; Hwang, IG; Jang, JS; Kim, HJ; Kim, JH; Kim, JW; Kim, SH; Kim, TY; Lee, JH; Shin, SH; Sun, S; Woo, IS | 1 |
| Cui, X; Liu, Z; Lv, X; Qi, Y; Shang, S; Zhao, J | 1 |
| Hanahan, D; Marinoni, I; Michael, IP; Perren, A; Saghafinia, S; Tichet, M; Zangger, N | 1 |
| Cadoo, KA; Cangemi, NA; Haqq, CM; Hyman, DM; Liu, JF; Makker, V; Navarro, WH; Rasco, DW; Tao, JJ | 1 |
| Loumaye, A; Thissen, JP | 1 |
| Calvo, F; Conway, EM; Lei, V; O'Byrne, AM; Suresh Babu, S; Valdez, Y; Xu, A | 1 |
| Castelli, G; Elvira, P; Testa, U | 1 |
| Chen, JL; Colgan, TD; Gregorevic, P; Hagg, A; Harrison, CA; Qian, H; Walton, KL; Watt, MJ | 1 |
| Bertona, M; Emanuele, E; Fiuza-Luces, C; Lucia, A; Morales, JS; Pareja-Galeano, H; Sanchis-Gomar, F | 1 |
| Chen, W; Ten Dijke, P | 1 |
| Moses, HL; Owens, P; Pickup, MW | 1 |
| Jiang, FX; Katik, I; Li, H; Liu, JP; Mackenzie-Kludas, C; Nicholls, C; Zhou, S | 1 |
| Katoh, M | 1 |
| Boone, T; Chen, Q; Goldberg, AL; Han, HQ; Jiao, Q; Kwak, KS; Lacey, DL; Lu, J; Rosenfeld, R; Simonet, WS; Song, Y; Wang, JL; Zhou, X | 1 |
| Vanchieri, C | 1 |
| Mathew, SJ | 1 |
| de Kretser, D; Henrik-Heldin, C | 1 |
| Dautry, F; Havard, M; Tchénio, T | 1 |
| Caja, L; Kahata, K; Moustakas, A | 1 |
| Fearon, KC; Glass, DJ; Guttridge, DC | 1 |
| Antsiferova, M; Werner, S | 1 |
| Shen, MM | 1 |
| Borawski, J; Myśliwiec, M; Naumnik, B | 1 |
| Gray, PC; Harrison, CA; Robertson, DM; Vale, WW | 1 |
| Imamura, T; Koinuma, D; Miyazono, K | 1 |
| Chang, CD; Chen, YG; Chuang, J; Chung, J; Lin, SL; Wang, Q; Ying, SY | 1 |
| Cui, X; Murakami, T; Nakatani, M; Tsuchida, K; Uezumi, A | 1 |
| Behringer, RR; Coerver, KA; Finegold, MJ; Kumar, TR; Lau, AL; Matzuk, MM; Shou, W | 1 |
| Harada, K; Saito, S; Sakamoto, Y; Shintani, Y; Shitsukawa, K; Wakatsuki, M | 1 |
| Bernard, DJ; Chapman, SC; Woodruff, TK | 1 |
| Phillips, DJ | 1 |
| Risbridger, GP; Robertson, DM; Schmitt, JF | 1 |
20 review(s) available for activins and Neoplasms
| Article | Year |
|---|---|
Activin-A in the regulation of immunity in health and disease.
Topics: Active Transport, Cell Nucleus; Activins; Animals; Autoimmune Diseases; Cell Nucleus; Dendritic Cells; Humans; Hypersensitivity; Leukocytes; Neoplasm Proteins; Neoplasms; Smad Proteins | 2019 |
Activin A: an emerging target for improving cancer treatment?
Topics: Activins; Animals; Biomarkers, Tumor; Cachexia; Drug Resistance, Neoplasm; Humans; Molecular Targeted Therapy; Neoplasms; Neovascularization, Pathologic; Tumor Microenvironment | 2020 |
Wound Repair, Scar Formation, and Cancer: Converging on Activin.
Topics: Activins; Animals; Biomarkers; Cicatrix; Disease Susceptibility; Fibroblasts; Humans; Neoplasms; Wound Healing | 2020 |
Perspectives of small molecule inhibitors of activin receptor‑like kinase in anti‑tumor treatment and stem cell differentiation (Review).
Topics: Activin Receptors; Activins; Animals; Cell Differentiation; Humans; Mesenchymal Stem Cells; Neoplasms; Signal Transduction; Small Molecule Libraries; Transforming Growth Factor beta | 2019 |
[Role of Activin A and Myostatin in cancer cachexia].
Topics: Activins; Animals; Cachexia; Humans; Mice; Mice, Knockout; Myostatin; Neoplasms | 2013 |
Experimental and investigational therapies for chemotherapy-induced anemia.
Topics: Activins; Anemia; Animals; Antineoplastic Agents; Disease Progression; Drug Design; Drugs, Investigational; Hematinics; Hepcidins; Humans; Neoplasms | 2015 |
Immunoregulation by members of the TGFβ superfamily.
Topics: Activins; Animals; Bone Morphogenetic Proteins; Gene Expression Regulation; Homeostasis; Humans; Immune System; Immunomodulation; Inflammation; Multigene Family; Neoplasms; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta | 2016 |
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment.
Topics: Activins; Animals; Bone Morphogenetic Proteins; Humans; Neoplasms; Signal Transduction; Transforming Growth Factor beta; Tumor Microenvironment | 2017 |
Context-dependent action of transforming growth factor β family members on normal and cancer stem cells.
Topics: Activins; Adult; Adult Stem Cells; Animals; Antineoplastic Agents; Bone Morphogenetic Proteins; Disease Progression; Drug Resistance, Neoplasm; Embryonic Stem Cells; Humans; Neoplasms; Neoplastic Stem Cells; Signal Transduction; Transforming Growth Factor beta | 2012 |
Cancer cachexia: mediators, signaling, and metabolic pathways.
Topics: Activins; Cachexia; Humans; Interleukin-6; Lipolysis; Metabolic Networks and Pathways; Models, Biological; Muscular Atrophy; Myostatin; Neoplasms; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |
The bright and the dark sides of activin in wound healing and cancer.
Topics: Activins; Animals; Cicatrix; Fibrosis; Humans; Neoplasms; Signal Transduction; Wound Healing | 2012 |
Decrypting the role of Cripto in tumorigenesis.
Topics: Activins; Amino Acid Motifs; Animals; Cell Division; Epidermal Growth Factor; GPI-Linked Proteins; Humans; Intercellular Signaling Peptides and Proteins; Membrane Glycoproteins; Models, Biological; Neoplasm Proteins; Neoplasms; Nodal Protein; Signal Transduction; Transforming Growth Factor beta; Tumor Cells, Cultured | 2003 |
[Activin A-follistatin: new cytokines, new perspectives].
Topics: Activins; Cytokines; Follistatin; Humans; Inhibin-beta Subunits; Kidney Diseases; Neoplasms | 2003 |
Antagonists of activin signaling: mechanisms and potential biological applications.
Topics: Activins; Animals; Cachexia; Hormone Antagonists; Humans; Neoplasms; Signal Transduction; Wound Healing | 2005 |
[TGF-beta family (TGF-beta, activin, BMP)].
Topics: Activins; Apoptosis; Bone Morphogenetic Proteins; Cell Differentiation; DNA-Binding Proteins; Fibrosis; Neoplasms; Neurons; Osteoblasts; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad Proteins; Trans-Activators; Transcription, Genetic; Transforming Growth Factor beta; Ubiquitin | 2005 |
Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis.
Topics: Activin Receptors; Activins; Apoptosis; Cell Differentiation; Cell Proliferation; Follistatin; Humans; Neoplasms; Signal Transduction; Smad2 Protein; Smad3 Protein | 2006 |
Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
Topics: Activin Receptors; Activins; Animals; Antineoplastic Agents; Bone Morphogenetic Proteins; Drug Delivery Systems; Epidermal Growth Factor; GPI-Linked Proteins; Humans; Intercellular Signaling Peptides and Proteins; Membrane Glycoproteins; Models, Biological; Musculoskeletal Diseases; Myostatin; Neoplasm Proteins; Neoplasms; Protein Binding; Protein Kinase Inhibitors; Signal Transduction; Transforming Growth Factor beta | 2008 |
Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development.
Topics: Activins; Animals; Growth; Inhibins; Mice; Mice, Knockout; Mice, Transgenic; Models, Biological; Neoplasms; Reproduction | 1996 |
Mechanisms of inhibin signal transduction.
Topics: Activin Receptors; Activins; Animals; DNA, Complementary; Female; Follicle Stimulating Hormone; Gene Expression Regulation; Humans; Inhibins; Ligands; Models, Biological; Neoplasms; Prostatic Secretory Proteins; Protein Binding; Protein Isoforms; Receptors, Peptide; Reproduction; Signal Transduction; Transforming Growth Factor beta | 2001 |
Activins and inhibins in endocrine and other tumors.
Topics: Activins; Animals; Endocrine Gland Neoplasms; Inhibins; Neoplasms; Signal Transduction; Tumor Suppressor Proteins | 2001 |
20 other study(ies) available for activins and Neoplasms
| Article | Year |
|---|---|
Targeting activins and inhibins to treat reproductive disorders and cancer cachexia.
Topics: Activins; Animals; Cachexia; Female; Follicle Stimulating Hormone; Humans; Inhibins; Mice; Neoplasms; Pregnancy | 2023 |
BRD9-mediated control of the TGF-β/Activin/Nodal pathway regulates self-renewal and differentiation of human embryonic stem cells and progression of cancer cells.
Topics: Activins; Cell Cycle Proteins; Cell Differentiation; Embryonic Stem Cells; Human Embryonic Stem Cells; Humans; Neoplasms; Nuclear Proteins; Transcription Factors; Transforming Growth Factor beta; Wnt Signaling Pathway | 2023 |
Generation of reporter cell lines for factors inducing muscle wasting in cancer cachexia.
Topics: Activins; Animals; Cachexia; Cell Line, Transformed; Genes, Reporter; Green Fluorescent Proteins; Humans; Mice; Mice, Inbred C57BL; Muscular Atrophy; Myoblasts; Myostatin; Neoplasms; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases | 2020 |
Circulating Activin A predicts survival in cancer patients.
Topics: Activins; Adipose Tissue; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Body Composition; Cachexia; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Muscle, Skeletal; Neoplasm Staging; Neoplasms; Nutritional Status; Organ Size; Prognosis; Young Adult | 2017 |
The Dynamics of TGF-β Signaling Are Dictated by Receptor Trafficking via the ESCRT Machinery.
Topics: Activins; Animals; Bone Morphogenetic Proteins; Cell Line; Down-Regulation; Endosomal Sorting Complexes Required for Transport; Epithelial-Mesenchymal Transition; Genome, Human; Humans; Lysosomes; Mice; Multivesicular Bodies; Neoplasms; Phosphorylation; Prognosis; Protein Transport; Proteolysis; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad2 Protein; Survival Analysis; Transforming Growth Factor beta; Ubiquitin-Protein Ligases; Up-Regulation | 2018 |
Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors.
Topics: Activins; Aged; Aged, 80 and over; Antineoplastic Agents; Biliary Tract Neoplasms; Biomarkers; C-Reactive Protein; Chemokine CXCL10; Collagen Type I; Colonic Neoplasms; Decision Trees; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibronectins; Humans; Interleukin-6; Liver Neoplasms; Lung Neoplasms; Male; Mortality; Myostatin; Neoplasm Metastasis; Neoplasms; Peptides; Prognosis; Republic of Korea; Sirtuin 1; Stomach Neoplasms; Survival Rate; Vascular Endothelial Growth Factor A; Vitamin D | 2019 |
ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.
Topics: Activin Receptors, Type I; Activins; Animals; Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Heterografts; Homeostasis; Humans; Male; Mice; Mice, Inbred A; Mice, Inbred C57BL; Mice, SCID; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Tumor Microenvironment | 2019 |
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors.
Topics: Activins; Antineoplastic Agents; Granulosa Cells; Humans; Maximum Tolerated Dose; Neoplasms; Ovarian Neoplasms; Treatment Outcome | 2019 |
TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells.
Topics: Activins; Animals; Antigens, CD; Antigens, Neoplasm; Bone Morphogenetic Protein 2; Cell Line, Tumor; Cytokines; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; RNA Stability; RNA, Messenger; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2014 |
Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia.
Topics: Activins; Animals; Blotting, Western; Cachexia; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Neoplasms; Polymerase Chain Reaction | 2016 |
Baicalin supplementation reduces serum biomarkers of skeletal muscle wasting and may protect against lean body mass reduction in cancer patients: Results from a pilot open-label study.
Topics: Absorptiometry, Photon; Activins; Aged; Biomarkers; Body Weight; Cachexia; Endpoint Determination; Female; Flavonoids; Humans; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Neoplasms; NF-kappa B; Pilot Projects; Wasting Syndrome; Weight Loss | 2016 |
Activin inhibits telomerase activity in cancer.
Topics: Activins; Down-Regulation; HeLa Cells; Humans; Neoplasms; Recombinant Proteins; Telomerase; Tumor Suppressor Proteins | 2009 |
Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based on TGFbeta, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors.
Topics: Activins; Animals; Base Sequence; Comparative Genomic Hybridization; Conserved Sequence; DNA-Binding Proteins; Forkhead Transcription Factors; Gene Expression; Gene Expression Regulation; Hepatocyte Nuclear Factor 3-beta; Humans; Mice; Molecular Sequence Data; Neoplasms; Nodal Protein; Octamer Transcription Factor-3; Promoter Regions, Genetic; Rats; Receptors, CXCR4; Signal Transduction; SOXF Transcription Factors; Stem Cells; Transcription Factors; Transcription, Genetic; Transforming Growth Factor beta | 2010 |
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.
Topics: Activin Receptors, Type II; Activins; Animals; Anorexia; Atrophy; Cachexia; Female; Humans; Inhibins; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myoblasts; Myocardium; Neoplasm Transplantation; Neoplasms; Signal Transduction; Transplantation, Heterologous; Tumor Necrosis Factor-alpha | 2010 |
Cachexia in cancer: is it treatable at the molecular level?
Topics: Activins; Cachexia; Humans; Muscle, Skeletal; Myostatin; Neoplasms; Receptors, Androgen | 2010 |
InACTIVatINg cancer cachexia.
Topics: Activin Receptors, Type II; Activins; Animals; Cachexia; Disease Models, Animal; Humans; Mice; Muscle, Skeletal; Neoplasms; Signal Transduction; Transforming Growth Factor beta | 2011 |
TGF-β down under 2011-the experts interviewed!
Topics: Activins; Congresses as Topic; Follistatin; Humans; Inhibins; Neoplasms; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta | 2011 |
A dormant state modulated by osmotic pressure controls clonogenicity of prostate cancer cells.
Topics: Activins; Animals; Cell Cycle; Cell Line, Tumor; Culture Media, Conditioned; Humans; Male; Mice; Neoplasm Metastasis; Neoplasms; NIH 3T3 Cells; Osmosis; Prostatic Neoplasms; Signal Transduction; Tumor Suppressor Protein p53 | 2011 |
Serum immunoreactive activin A levels in normal subjects and patients with various diseases.
Topics: Activins; Adult; Aged; Aged, 80 and over; Aging; Endocrine System Diseases; Female; Growth Substances; Humans; Inhibins; Liver Diseases; Male; Middle Aged; Neoplasms; Pregnancy; Radioimmunoassay; Reference Values; Sex Characteristics | 1996 |
New developments in the biology of inhibins, activins and follistatins.
Topics: Activin Receptors; Activins; Animals; Cell Division; Female; Follistatin; Glycoproteins; Humans; Inflammation; Inhibins; Neoplasms; Pituitary-Adrenal System; Pregnancy; Receptors, Growth Factor; Receptors, Peptide; Wound Healing | 2001 |